Men with prostate cancer that has spread outside the prostate to other parts of the body (advanced prostate cancer) may have radiotherapy to help relieve symptoms. This is called palliative radiotherapy. Palliative radiotherapy doesn't aim to get rid of your cancer but it can help to slow down its growth.

There are two types of radiotherapy to help relieve symptoms.

  • External beam radiotherapy (EBRT) uses high energy X-ray beams which are directed at the area of pain from outside of the body.
  • Radioisotope treatment involves an injection of a very small amount of a radioactive substance.

Radiotherapy may be used to treat symptoms such as pain, blood in the urine, and swollen lymph nodes. It can also be used to treat a rare condition called metastatic spinal cord compression (MSCC) when cancer cells grow in or near to the spine and press on the spinal cord. You can read more about MSCC in our fact sheet, Metastatic spinal cord compression.

What other treatments are available?

What are the advantages and disadvantages?

The advantages and disadvantages depend on your general health, previous treatment and how far your cancer has spread.


  • Radiotherapy may help relieve your symptoms for several months and improve day-to-day life
  • It may slow down the growth of the cancer in the area that's treated
  • Treatment works quite quickly. You should have some pain relief within a few weeks
  • You might be able to reduce the dose of any pain-relieving drugs you're taking. This could be useful if they are causing side effects.


  • Like most treatments, radiotherapy can cause side effects
  • You might have slightly more pain during treatment, and for a few days afterwards. This should soon improve
  • The pain can come back after several months. If this happens, you might need further treatment with radiotherapy or other treatments.

What does treatment involve?

External beam radiotherapy (EBRT)
Before starting EBRT you will go to a planning session.

You'll have either one single dose or a series of smaller doses of radiotherapy spread out over a week or more.

At the beginning of each treatment, the radiographers will help move you into the right position on the treatment couch. The radiotherapy machine moves around your body and will make a slight noise. It doesn't touch you and you won't feel anything. You'll need to lie still, but the treatment only lasts a few minutes. You should be able to go home after the treatment has finished.

If you have pain in several areas of your body, you may have hemi-body radiotherapy. This is radiotherapy to half your body - the upper or lower half, depending on where you have pain.

Treatment with radioisotopes can be helpful if you have pain in more than one area. Tell your doctor if you are taking prescription or over-the-counter medicines, or you have a history of blood disorders, bone marrow problems or kidney disease.

Strontium-89 (Metastron®) is a radioisotope that can be used to relieve pain in men with advanced prostate cancer. A very small amount is given as an injection into a vein in your arm.

After treatment

Your doctor will monitor you and your symptoms. Pain can sometimes get worse during treatment and for a few days afterwards - called a pain flare.

You should notice that the pain gradually improves, though it might take a few weeks for the treatment to be most effective. The pain relief usually lasts for several months.

If your pain or symptoms don't improve, you may be offered another course of radiotherapy or a different treatment to help control symptoms. You can read about these in our fact sheet Managing pain in advanced prostate cancer.

What are the side effects?

There are usually few side effects from EBRT. If you have hemi-body radiotherapy you might have more side effects because a larger area of the body is treated. These are some of the most common side effects of EBRT and hemi-body radiotherapy.

  • Some men feel tired for a week or two after treatment finishes
  • Your skin might get darker and itch in the area treated, similar to sunburn. Avoid using any creams, lotions or perfumed soaps unless you are advised to do so by your doctor, radiographer or nurse
  • Radiotherapy to your ribs or spine can make you feel or be sick - anti-sickness medication can help treat this
  • Radiotherapy to your lower body can lead to loose and watery stools (diarrhoea) - there are medications to help treat this
  • You might have slightly more pain during the course of treatment or for a few days after it has finished - this should soon get better.


Most side effects of strontium-89 only last a short time and are not severe.

  • Some men have more pain in the days after treatment, but this should only last for a few days
  • Sometimes the bone marrow is affected which might change the way that your blood clots and increase your risk of infection and anaemia. You may get a fever, chills, bruising, bleeding or tiredness. It is rare for infection or anaemia to be severe, but you might need regular blood tests after treatment
  • You may feel or be sick (nausea or vomiting) or have diarrhoea. This is not common.

Questions to ask your doctor or nurse

  • How will radiotherapy help me?
  • What other treatments are available to help me with my pain?
  • Which type of radiotherapy is best for me?
  • How long will the pain relief last?
  • Will there be any side effects from the treatment? What can help with these?
  • Are there any precautions that I need to take during and after treatment?
  • Who should I contact if I have any questions at any point during my treatment? How do I contact them?
  • Will having this treatment mean I am unable to have other types of treatment later on (for example, chemotherapy)?


Updated: Jun 2013 | Due for Review: Jun 2015

  • Full list of references used to produce this page  

    1 Din OS, Thanvi N, Ferguson CJ, Kirkbride P. Palliative radiotherapy for symptomatic advanced prostate cancer. Radiotherapy and Oncology. 2009;93:192-196.

    2 National Institute for Health and Clinical Excellence, Prostate Cancer: diagnosis and treatment (Full guidance). February 2008

    3 The British Pain Society. Cancer Pain Management. A perspective from the British Pain Society, supported by the Association for Palliative Medicine and the Royal College of General Practitioners. January 2010.

    4 James ND, Bloomfield D, Luscombe C. The changing pattern of management for hormone-refractory, metastatic prostate cancer: Review. Prostate Cancer and Prostatic Diseases 2006; 9: 221-229.

    5 Loblaw DA, Wu JS, Jackson S, Kirkbride P. Pain flare in patients with bone metastases after palliative radiotherapy--a nested randomized control trial. Supportive Care in Cancer. 2007;15(4):451-5.

    6 Chow E, Ling A, Davis L et al. Pain flare following external beam radiotherapy and meaningful change in pain scores in the treatment of bone metastases. Journal of the European Society for Therapeutic Radiology and Oncology 2005; 75/1: 64-9.

    7 Hird A, Chow E, Zhang L, et al. Determining the incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: results from three canadian cancer centers. Int J Radiat Oncol Biol Phys. 2009;75(1):193-7.

    8 Bashir FA, Parry JM & Windsor PM. Use of a modified hemi-body irradiation technique for metastatic carcinoma of the prostate: Report of a 10-year experience. Clinical Oncology. 2008;20:591-598.

    9 Clarke N. Management of the spectrum of hormone refractory prostate cancer. European Urology. 2006;50:428-439.

    10 Jager PL. Treatment with radioactive strontium for patients with bone metastases from prostate cancer. BJU International 2000; 86: 929-934.

    11 Finlay IG, Mason M D & Shelley M. Radioisotopes for the palliation of metastatic bone cancer: a systematic review. Lancet Oncology 2005;6:392-400.

    12 British Uro-oncology Group (BUG), British Association of Urological Surgeons (BAUS), British Prostate Group (BPG). MDT (Multi-disciplinary Team) Guidance for managing prostate cancer. 2nd Edition. 2009.

    13 Notes for Guidance on the Clinical Administration of Radiopharmaceuticals and Use of Sealed Radioactive Sources. Administration of Radioactive Substances Advisory Committee 2006.

    14 GE Healthcare. Metastron (Strontium-89 chloride injection). 2006.

    15 Oosterhof GON, Roberts JT, de Reijke Th.M, et al. Strontium89 Chloride versus Palliative Local Field Radiotherapy in Patientswith Hormonal Escaped Prostate Cancer: A Phase II Studyof the European Organisation for Research andTreatment of Cancer Genitourinary Group. European Urology. 44 (2003) 519-526

    16 Li KK, Hadi S, Kirou-Mauro A et al. When should we define the response rates in the treatment of bone metastases by palliative radiotherapy? Clinical Oncology (Royal College of Radiologists). 2008;20(1):83-9.

    17 Lutz S, Berk L, Chang E, et al. Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline. Int. J. Radiation Oncology Biol. Phys. 2011;79(4):965-976.